How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence. By Cade Metz Reporting from San ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The celebrities have all walked up the steps at the 2026 Met Gala, and left us with much to discuss. As they do every year, some of the biggest names in film, fashion and music attended the exclusive ...

How on earth did the Aussie actor wind up buying a pub he'd never set foot in? Here, Shane Jacobson explains all. Thankfully though, the 56-year-old Kenny star is ...

The Paris Climate Accords in 2015 set an ambitious (and necessary) goal of keeping global temperatures at 1.5 degrees Celsius above pre-industrial temps. But a study says we might’ve blown past that ...

Python stays far ahead after another dip; C holds second, Java retakes third from C++, and R rises to eighth as SQL slips, with Delphi steady in tenth. May’s TIOBE Index has one of those charts that ...